SCHEMBL29939355

SCHEMBL29939355

CCOC(=O)c1c(-c2ccc(NC(C)C)nc2C)nn2cccnc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 1/20 0.42
ALDH1A1 P00352 4/20 0.38
HPGD P15428 3/20 0.38
KDM4E B2RXH2 3/20 0.38
LMNA P02545 2/20 0.38
HSD17B10 Q99714 2/20 0.38
THRB P10828 1/20 0.37
ADORA3 P0DMS8 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA2B P29275 1/20 0.36
ADORA1 P30542 1/20 0.36
JAK2 O60674 2/20 0.36
JAK3 P52333 2/20 0.36
TGFBR1 P36897 2/20 0.35
HTR6 P50406 1/20 0.35
MAPT P10636 2/20 0.35
GAA P10253 1/20 0.35
IDO1 P14902 1/20 0.35
PIK3CD O00329 2/20 0.34
PIK3CG P48736 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23013420 0.91 PDE2A (0.39) PDE2AALDH1A1HPGDKDM4ELMNA
SCHEMBL29692238 0.91 PDE2A (0.39) PDE2AALDH1A1HPGDKDM4ELMNA
SCHEMBL29692275 0.84 PDE2A (0.40) PDE2AALDH1A1HPGDKDM4ELMNA
SCHEMBL23013253 0.84 PDE2A (0.40) PDE2AALDH1A1HPGDKDM4ELMNA
SCHEMBL29939203 0.83 ALDH1A1 (0.41) PDE2AALDH1A1HPGDKDM4ELMNA
SCHEMBL29939524 0.83 JAK2 (0.40) PDE2AALDH1A1HPGDKDM4ELMNA
SCHEMBL30029568 0.81 PDE2A (0.42) PDE2AALDH1A1HPGDKDM4ELMNA
SCHEMBL23013307 0.79 PDE2A (0.38) PDE2AALDH1A1HPGDKDM4ELMNA
SCHEMBL29692226 0.79 PDE2A (0.38) PDE2AALDH1A1HPGDKDM4ELMNA
SCHEMBL29939592 0.77 ALDH1A1 (0.40) PDE2AALDH1A1HPGDKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12227507-B2 Pharmaceutical compounds PFIZER INC. (US) 2025-02-18 US disclosed
US-11634425-B2 Pharmaceutical compounds PFIZER INC. (US) 2023-04-25 US disclosed
US-20220324873-A1 PHARMACEUTICAL COMPOUNDS PFIZER INC. 2022-10-13 US disclosed
US-20220306639-A1 PHARMACEUTICAL COMPOUNDS PFIZER INC. 2022-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12227507-B2 Pharmaceutical compounds CHRNA6, GABRA6, CHRNA7 PDE2A 4652/4885ALDH1A1 3480/4885HPGD 3391/4885
US-11634425-B2 Pharmaceutical compounds GABRA6, CHRNA6, CNR1 PDE2A 4484/4885ALDH1A1 3010/4885HPGD 3197/4885
US-20220306639-A1 PHARMACEUTICAL COMPOUNDS CHRNA6, GABRA6, CHRNA7 PDE2A 4652/4885ALDH1A1 3480/4885HPGD 3391/4885
US-20220324873-A1 PHARMACEUTICAL COMPOUNDS GABRA6, CNR1, CHRNA6 PDE2A 4480/4885ALDH1A1 3112/4885HPGD 3337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.